HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.

WASHINGTON (January 10, 2023) – In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study ...

SAN FRANCISCO -- Operators had a favorable early experience using the Tendyne transcatheter mitral valve replacement (TMVR) system for severe mitral regurgitation (MR) and mitral annular calcification ...

HighLife Receives CE Mark Approval for its TMVR SolutionParis, January 26, 2026 – HighLife SAS, a leading MedTech company focused on ...

PHOENIX, AZ—Symptomatic patients with moderate-to-severe mitral regurgitation (MR) ineligible for surgery fare quite well with transapical (TA) transcatheter mitral valve replacement (TMVR), with more ...

Most devicemakers aiming to provide a treatment for mitral regurgitation—see Abbott, Medtronic, InnovHeart and more—are doing so by developing implants that are placed directly within a faulty mitral ...

WICHITA, Kan. (KSNW) — A surgical team at Ascension Via Christi-St. Francis has performed a first-of-its-kind heart valve replacement procedure. The 65-year-old woman from Hutchinson is the first ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making it the first minimally invasive, catheter-based treatment that uses a ...